Tandem Diabetes Care Q2 Earnings Call Highlights
Tandem Diabetes Care reported second-quarter results featuring record sales, pump shipments, and gross margin for a second quarter. Management highlighted early progress in its transition to pharmacy-channel reimbursement and continued development of new insulin-delivery technologies.
Why it matters — TNDM watchers would note the record second-quarter sales and gross margin, alongside early progress on the pharmacy-channel reimbursement transition that could shape future growth.